5′ Adenosine Monophosphate-Activated Protein Kinase, Metabolism and Exercise

Sports Medicine

Volumn 34, Issue 2, 2004, Pages 91-103

  Aschenbach, William G ^a   Sakamoto, Kei ^a   Goodyear, Laurie J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FATTY ACID; PROTEIN;

ADAPTATION; CARBOHYDRATE METABOLISM; CATALYSIS; CATALYST; CELL ENERGY; ENDURANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; EXERCISE; FATTY ACID METABOLISM; GENE EXPRESSION; GLUCOSE TRANSPORT; HUMAN; MUSCLE CONTRACTION; PHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN STRUCTURE; REVIEW; SKELETAL MUSCLE; ENZYMOLOGY; METABOLISM;

CARBOHYDRATE METABOLISM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXERCISE; FATTY ACIDS; GENE EXPRESSION; GLUCOSE; HUMANS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PROTEINS;

EID: 1442332885     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-200434020-00003     Document Type: Review

References (89)

1. Holloszy JO, Booth FW. Biochemical adaptations to endurance exercise in muscle. Annu Rev Physiol 1976; 38: 273-91
2. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998; 67: 821-55
3. Hardie DG, Carling D. The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem 1997; 246 (2): 259-73
4. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 1999; 277 (1 Pt 1): E1-10
5. Winder WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 2001; 91 (3): 1017-28
6. Goodyear LJ. AMP-activated protein kinase: a critical signaling intermediary for exercise-stimulated glucose transport? Exerc Sport Sci Rev 2000; 28 (3): 113-6
7. Sakamoto K, Goodyear LJ. Invited review: intracellular signaling in contracting skeletal muscle. J Appl Physiol 2002; 93 (1): 369-83
8. Musi N, Goodyear LJ. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2002; 2: 119-27
9. Hawley SA, Davison M, Woods A, et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 1996; 271 (44): 27879-87
10. Thornton C, Snowden MA, Carling D. Identification of a novel AMP-activated protein kinase β subunit isoform that is highly expressed in skeletal muscle. J Biol Chem 1998; 273 (20): 12443-50
11. Stapleton D, Mitchelhill KI, Gao G, et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 1996; 271 (2): 611-4
12. Fujii N, Hayashi T, Hirshman MF, et al. Exercise induces isoform-specific increase in 5′ AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 2000; 273 (3): 1150-5
13. 2 isoform. Biochem J 1998; 334 (Pt 1): 177-87
14. Ai H, Ihlemann J, Hellsten Y, et al. Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle. Am J Physiol Endocrinol Metab 2002; 282 (6): E1291-300
15. Warden SM, Richardson C, O'Donnell JJ, et al. Post-translational modifications of the β-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J 2001; 354 (Pt 2): 275-83
16. Chen Z, Heierhorst J, Mann RJ, et al. Expression of the AMP-activated protein kinase β1 and β2 subunits in skeletal muscle. FEBS Lett 1999; 460 (2): 343-8
17. Cheung PC, Salt IP, Davies SP, et al. Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem J 2000; 346 (Pt 3): 659-69
18. Durante PE, Mustard KJ, Park SH, et al. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am J Physiol Endocrinol Metab 2002; 283 (1): E178-86
19. Hayashi T, Hirshman MF, Fujii N, et al. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 2000; 49: 527-31
20. Hawley SA, Selbert MA, Goldstein EG, et al. 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/ calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 1995; 270 (45): 27186-91
21. Davies SP, Helps NR, Cohen PT, et al. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase: studies using bacterially expressed human protein phosphatase-2Cα and native bovine protein phosphatase-2AC. FEBS Lett 1995; 377 (3): 421-5
22. Hardie DG, Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001; 23 (12): 1112-9
23. Derave W, Ai H, Ihlemann J, et al. Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes 2000; 49 (8): 1281-7
24. Wojtaszewski JF, Mourtzakis M, Hillig T, et al. Dissociation of AMPK activity and ACCβ phosphorylation in human muscle during prolonged exercise. Biochem Biophys Res Commun 2002; 298 (3): 309-16
25. Wojtaszewski JF, Jorgensen SB, Hellsten Y, et al. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA) riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 2002; 51 (2): 284-92
26. Wojtaszewski JF, MacDonald C, Nielsen JN, et al. Regulation of 5′ AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 2003; 284 (4): E813-22
27. 2. Biochem Biophys Res Commun 2001; 287 (1): 92-7
28. Halse R, Fryer LG, McCormack JG, et al. Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase. Diabetes 2003; 52 (1): 9-15
29. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 1996; 270 (2 Pt 1): E299-304
30. Rasmussen BB, Winder WW. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J Appl Physiol 1997; 83 (4): 1104-9
31. Rasmussen BB, Hancock CR, Winder WW. Postexercise recovery of skeletal muscle malonyl-CoA, acetyl-CoA carboxylase, and AMP-activated protein kinase. J Appl Physiol 1998; 85 (5): 1629-34
32. Hutber CA, Hardie DG, Winder WW. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am J Physiol 1997; 272 (2 Pt 1): E262-6
33. Vavvas D, Apazidis A, Saha AK, et al. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 1997; 272 (20): 13255-61
34. Hayashi T, Hirshman MF, Kurth EJ, et al. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47 (8): 1369-73
35. Ihlemann J, Ploug T, Hellsten Y, et al. Effect of tension on contraction-induced glucose transport in rat skeletal muscle. Am J Physiol 1999; 277 (2 Pt 1): E208-14
36. Musi N, Fujii N, Hirshman MF, et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001; 50 (5): 921-7
37. Wojtaszewski JF, Nielsen P, Hansen BF, et al. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol 2000; 528 Pt 1: 221-6
38. Stephens TJ, Chen ZP, Canny BJ, et al. Progressive increase in human skeletal muscle AMPKα2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 2002; 282 (3): E688-94
39. Chen ZP, McConell GK, Michell BJ, et al. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 2000; 279 (5): E1202-6
40. Musi N, Hayashi T, Fujii N, et al. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol 2001; 280 (5): E677-84
41. Brooks G, Fahey T, White T. Neurons, motor unit recruitment, and intergrative control of movement Exercise physiology: human bioenergetics and its applications. Mountain View (CA): Mayfield, 2000
42. Holloszy JO. A forty-year memoir of research on the regulation of glucose transport into muscle. Am J Physiol Endocrinol Metab 2003; 284 (3): E453-67
43. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998; 49: 235-61
44. Goodyear LJ, Hayashi T. Effects of exercise on glucose transport in skeletal muscle: glucose transporters and intracellular signaling mechanisms. In: Nose H, Nadel ER, Morimoto T, editors. The 1997 Nagano Symposium on sports sciences. Carmel (IL): Cooper, 2001: 83-93
45. Merrill GF, Kurth EJ, Hardie DG, et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 1997; 273 (36): E1107-12
46. Vincent MF, Marangos PJ, Gruber HE, et al. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 1991; 40 (10): 1259-66
47. Bergeron R, Russell III RR, Young LH, et al. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 1999; 276 (5 Pt 1): E938-44
48. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, et al. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999; 48 (8): 1667-71
49. Gruber HE, Hoffer ME, McAllister DR, et al. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: effects on flow, granulocytes, and injury. Circulation 1989; 80 (5): 1400-11
50. Young ME, Radda GK, Leighton B. Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR: an activator of AMP-activated protein kinase. FEBS Lett 1996; 382: 43-7
51. Mu J, Brozinick Jr JT, Valladares O, et al. A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 2001; 7 (5): 1085-94
52. Aschenbach WG, Hirshman MF, Fujii N, et al. Effect of AICAR treatment on glycogen metabolism in skeletal muscle. Diabetes 2002; 51 (3): 567-73
53. Bergeron R, Previs SF, Cline GW, et al. Effect of 5-aminoimidazole-4- carboxamide- 1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 2001; 50 (5): 1076-82
54. Carling D, Hardie DG. The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta 1989; 1012 (1): 81-6
55. Beyer A, Kitzerow A, Crute B, et al. Muscle phosphorylase kinase is not a substrate of AMP-activated protein kinase. Biol Chem 2000; 381 (5-6): 457-61
56. Michell BJ, Stapleton D, Mitchelhill KI, et al. Isoform-specific purification and substrate specificity of the 5′ AMP-activated protein kinase. J Biol Chem 1996; 271 (45): 28445-50
57. Holmes BF, Kurth-Kraczek EJ, Winder WW. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 1999; 87 (5): 1990-5
58. Javaux F, Vincent MF, Wagner DR, et al. Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside: lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells. Biochem J 1995; 305 (Pt 3): 913-9
59. Hue L, Beauloye C, Marsin AS, et al. Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. J Mol Cell Cardiol 2002; 34 (9): 1091-7
60. Marsin AS, Bertrand L, Rider MH, et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 2000; 10 (20): 1247-55
61. Cadefau JA, Parra J, Tauler A, et al. Contractile activity modifies Fru-2,6-P2 metabolism in rabbit fast twitch skeletal muscle. J Biol Chem 1999; 274 (45): 31961-6
62. Kaushik VK, Young ME, Dean DJ, et al. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab 2001; 281 (2): E335-40
63. Ivy JL, Kuo CH. Regulation of GLUT4 protein and glycogen synthase during muscle glycogen synthesis after exercise. Acta Physiol Scand 1998; 162 (3): 295-304
64. Buhl ES, Jessen N, Schmitz O, et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 2001; 50 (1): 12-7
65. Winder WW, Holmes BF, Rubink DS, et al. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 2000; 88 (6): 2219-26
66. Milan D, Jeon JT, Looft C, et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 2000; 288 (5469): 1248-51
67. McGarry JD. Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biochem Soc Trans 1995; 23 (3): 481-5
68. Ruderman NB, Saha AK, Vavvas D, et aL Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 1999; 276 (1 Pt 1): E1-E18
69. Dean D, Daugaard JR, Young ME, et al. Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. Diabetes 2000; 49 (8): 1295-300
70. Park SH, Gammon SR, Knippers JD, et al. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol 2002; 92 (6): 2475-82
71. Saha AK, Schwarsin AJ, Roduit R, et al. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J Biol Chem 2000; 275 (32): 24279-83
72. Park H, Kaushik VK, Constant S, et al. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem 2002; 277 (36): 32571-7
73. Yu M, Stepto NK, Chibalin AV, et al. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol 2003; 546 (Pt 2): 327-35
74. Winder WW, Wilson HA, Hardie DG, et al. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 1997; 82 (1): 219-25
75. Habinowski SA, Hirshman M, Sakamoto K, et al. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. Arch Biochem Biophys 2001; 396 (1): 71-9
76. Spriet LL, Dyck DJ. The glucose-fatty acid cycle in skeletal muscle at rest and during exercise. In: Maughan RJ, Shisheva A, editors. Biochemistry of exercise. Aberdeen: Human Kinetics Publishers Inc., 2003: 127-56
77. Bolster DR, Crozier SJ, Kimball SJ, et al. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002; 277 (27): 23977-80
78. Williams RS, Neufer PD. Regulation of gene expression in skeletal muscle by contractile activity. Handbook Physiol 1999; 12: 1124-50
79. Zheng D, MacLean PS, Pohnert SC, et al. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 2001; 91 (3): 1073-83
80. Ojuka EO, Nolte LA, Holloszy JO. Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro. J Appl Physiol 2000; 88 (3): 1072-5
81. Ojuka EO, Jones TE, Nolte LA, et al. Regulation of GLUT4 biogenesis in muscle; evidence for involvement of AMPK and Ca2+. Am J Physiol Endocrinol Metab 2002; 282 (5); E1008-13
82. Zhou M, Lin BZ, Coughlin S, et al. UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase. Am J Physiol Endocrinol Metab 2000; 279 (3): E622-9
83. Stoppani J, Hildebrandt AL, Sakamoto K, et al. AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle. Am J Physiol Endocrinol Metab 2002; 283 (6): E1239-48
84. Bergeron R, Ren JM, Cadman KS, et al. Chronic activation of AMP kinase resulls in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 2001; 281 (6): E1340-6
85. Zong H, Ren JM, Young LH, et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A 2002; 99 (25): 15983-7
86. Wu H, Kanatous SB, Thurmond FA, et al. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 2002; 296 (5566): 349-52
87. 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J Biol Chem 2002; 277 (52): 51017-24
88. 2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001; 10 (11): 1215-20
89. Tian R, Musi N, D'Agostino J, et al. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hyper[trophy. Circulation 2001; 104 (14): 1664-9